Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Shenfu injection** is a Chinese prescription herbal injection derived from the traditional Shenfu decoction. It is a fixed multi-herb product prepared from red ginseng (*Panax ginseng*) and processed aconite root (*Aconitum carmichaeli*), containing a chemically complex mixture that includes ginsenosides and processed aconite-derived diterpene alkaloids. It is used in China as an adjunctive treatment in shock and critical-care settings, including septic shock and cardiogenic shock. Clinical studies in sepsis have reported signals for improved lactate reduction, shorter vasopressor exposure, and some hemodynamic or immunologic effects, but randomized trials have not consistently demonstrated a statistically significant 28-day mortality benefit. The product is manufactured in China by China Resources Sanjiu. ([pdfs.semanticscholar.org](https://pdfs.semanticscholar.org/a3d8/dd69c6a42fdf9d9a215a4a903d212407f539.pdf))
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on shenfu injection.